Geneos Wealth Management Inc. Teva Pharmaceutical Industries LTD Transaction History

Geneos Wealth Management Inc.

  • $2.6 Billion
  • Q3 2024

A detailed history of Geneos Wealth Management Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 42,522 shares of TEVA stock, worth $961,847. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,522
Previous 47,082 9.69%
Holding current value
$961,847
Previous $765,000 0.13%
% of portfolio
0.03%
Previous 0.03%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.81 - $18.96 $72,093 - $86,457
-4,560 Reduced 9.69%
42,522 $766,000
Q2 2024

Jul 23, 2024
BUY
$12.78 - $17.4 $1,278 - $1,739
100 Added 0.21%
47,082 $765,000
Q1 2024

May 03, 2024
SELL
$10.67 - $14.43 $1,216 - $1,645
-114 Reduced 0.24%
46,982 $662,000
Q4 2023

Jan 26, 2024
SELL
$8.12 - $10.63 $24,359 - $31,890
-3,000 Reduced 5.99%
47,096 $491,000
Q3 2023

Oct 11, 2023
SELL
$7.48 - $10.7 $8,871 - $12,690
-1,186 Reduced 2.31%
50,096 $510,000
Q2 2023

Aug 08, 2023
BUY
$7.2 - $9.47 $1,440 - $1,894
200 Added 0.39%
51,282 $386,000
Q1 2023

Apr 25, 2023
SELL
$8.36 - $11.37 $3,970 - $5,400
-475 Reduced 0.92%
51,082 $452,000
Q4 2022

Jan 30, 2023
SELL
$7.95 - $9.48 $24,645 - $29,388
-3,100 Reduced 5.67%
51,557 $470,000
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $76,317 - $132,943
-11,125 Reduced 16.91%
54,657 $441,000
Q2 2022

Jul 22, 2022
SELL
$7.38 - $10.4 $45,756 - $64,480
-6,200 Reduced 8.61%
65,782 $494,000
Q1 2022

May 16, 2022
BUY
$7.33 - $9.39 $80,952 - $103,703
11,044 Added 18.12%
71,982 $675,000
Q4 2021

Feb 09, 2022
BUY
$7.9 - $10.19 $48,450 - $62,495
6,133 Added 11.19%
60,938 $488,000
Q3 2021

Nov 09, 2021
SELL
$8.38 - $10.18 $6,704 - $8,144
-800 Reduced 1.44%
54,805 $531,000
Q2 2021

Jul 08, 2021
SELL
$9.9 - $11.56 $53,271 - $62,204
-5,381 Reduced 8.82%
55,605 $546,000
Q1 2021

Jun 17, 2021
SELL
$10.34 - $12.81 $5,904 - $7,314
-571 Reduced 0.93%
60,986 $652,000
Q4 2020

May 19, 2021
BUY
$8.61 - $11.04 $126,136 - $161,736
14,650 Added 31.23%
61,557 $639,000
Q3 2020

Sep 07, 2021
SELL
$8.57 - $12.69 $74,259 - $109,958
-8,665 Reduced 15.59%
46,907 $409,000
Q2 2020

Sep 07, 2021
BUY
$8.12 - $13.12 $77,545 - $125,295
9,550 Added 20.75%
55,572 $677,000
Q1 2020

Sep 07, 2021
BUY
$6.69 - $13.45 $59,728 - $120,081
8,928 Added 24.07%
46,022 $347,000
Q4 2019

Sep 07, 2021
BUY
$6.53 - $10.72 $16,651 - $27,336
2,550 Added 7.38%
37,094 $369,000
Q3 2019

Sep 07, 2021
SELL
$6.16 - $9.6 $1,891 - $2,947
-307 Reduced 0.88%
34,544 $239,000
Q2 2019

Sep 07, 2021
BUY
$8.12 - $15.72 $10,718 - $20,750
1,320 Added 3.94%
34,851 $321,000
Q1 2019

Sep 07, 2021
BUY
$15.58 - $20.01 $10,983 - $14,107
705 Added 2.15%
33,531 $525,000
Q4 2018

Sep 07, 2021
SELL
$14.59 - $23.84 $28,450 - $46,488
-1,950 Reduced 5.61%
32,826 $515,000
Q3 2018

Sep 07, 2021
BUY
$21.06 - $25.65 $481,894 - $586,923
22,882 Added 192.38%
34,776 $749,000
Q2 2018

Sep 07, 2021
SELL
$16.77 - $24.71 $166,978 - $246,037
-9,957 Reduced 45.57%
11,894 $289,000
Q1 2018

Sep 07, 2021
SELL
$16.68 - $22.07 $287,429 - $380,310
-17,232 Reduced 44.09%
21,851 $373,000
Q4 2017

Sep 07, 2021
SELL
$11.23 - $19.1 $12,072 - $20,532
-1,075 Reduced 2.68%
39,083 $740,000
Q3 2017

Sep 07, 2021
SELL
$15.41 - $32.17 $16,904 - $35,290
-1,097 Reduced 2.66%
40,158 $706,000
Q2 2017

Sep 07, 2021
BUY
N/A
11,885 Added 40.47%
41,255 $1.37 Million
Q1 2017

Sep 07, 2021
BUY
N/A
3,434 Added 13.24%
29,370 $942,000
Q4 2016

Sep 07, 2021
BUY
N/A
19,085 Added 278.57%
25,936 $940,000
Q3 2016

Sep 07, 2021
BUY
N/A
333 Added 5.11%
6,851 $315,000
Q2 2016

Sep 07, 2021
SELL
N/A
-317 Reduced 4.64%
6,518 $326,000
Q1 2016

Sep 07, 2021
BUY
N/A
6,835
6,835 $370,000

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email